BNP Paribas Asset Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.1M | Sell |
897,419
-163,387
| -15% | -$4.6M | 0.03% | 530 |
|
|
2026
Q1 | $30.3M | Buy |
1,060,806
+101,512
| +11% | +$3.46M | 0.04% | 456 |
|
|
2025
Q4 | $38M | Buy |
959,294
+192,156
| +25% | +$7.04M | 0.04% | 367 |
|
|
2025
Q3 | $27M | Buy |
767,138
+11,601
| +2% | +$400K | 0.07% | 279 |
|
|
2025
Q2 | $24.8M | Buy |
755,537
+7,731
| +1% | +$251K | 0.06% | 305 |
|
|
2025
Q1 | $24.1M | Buy |
747,806
+147,000
| +24% | +$5.46M | 0.06% | 292 |
|
|
2024
Q4 | $18.4M | Buy |
600,806
+100,157
| +20% | +$3.22M | 0.05% | 367 |
|
|
2024
Q3 | $14M | Buy |
500,649
+119,929
| +32% | +$2.96M | 0.03% | 378 |
|
|
2024
Q2 | $8.67M | Buy |
380,720
+2,898
| +0.8% | +$66.9K | 0.02% | 444 |
|
|
2024
Q1 | $11.5M | Sell |
377,822
-78,940
| -17% | -$2.64M | 0.03% | 407 |
|
|
2023
Q4 | $16.3M | Sell |
456,762
-38,711
| -8% | -$1.44M | 0.05% | 327 |
|
|
2023
Q3 | $21.7M | Buy |
495,473
+14,199
| +3% | +$693K | 0.07% | 278 |
|
|
2023
Q2 | $23.8M | Sell |
481,274
-148,124
| -24% | -$6.83M | 0.07% | 262 |
|
|
2023
Q1 | $26.1M | Buy |
629,398
+26,617
| +4% | +$1.1M | 0.09% | 239 |
|
|
2022
Q4 | $26.8M | Buy |
602,781
+102,977
| +21% | +$4.3M | 0.1% | 246 |
|
|
2022
Q3 | $19.5M | Buy |
499,804
+31,717
| +7% | +$1.45M | 0.08% | 284 |
|
|
2022
Q2 | $19.1M | Buy |
468,087
+30,542
| +7% | +$1.45M | 0.07% | 293 |
|
|
2022
Q1 | $28.7M | Sell |
437,545
-23,725
| -5% | -$1.54M | 0.1% | 240 |
|
|
2021
Q4 | $32.1M | Buy |
461,270
+29,582
| +7% | +$2.15M | 0.11% | 232 |
|
|
2021
Q3 | $30M | Buy |
431,688
+51,000
| +13% | +$3.92M | 0.11% | 218 |
|
|
2021
Q2 | $30.2M | Sell |
380,688
-81,425
| -18% | -$5.92M | 0.11% | 235 |
|
|
2021
Q1 | $30.3M | Sell |
462,113
-147,273
| -24% | -$9.07M | 0.12% | 196 |
|
|
2020
Q4 | $33.9M | Buy |
609,386
+79,637
| +15% | +$3.44M | 0.16% | 162 |
|
|
2020
Q3 | $21.1M | Buy |
529,749
+126,244
| +31% | +$5.35M | 0.12% | 211 |
|
|
2020
Q2 | $18.1M | Sell |
403,505
-164,894
| -29% | -$7.18M | 0.12% | 201 |
|
|
2020
Q1 | $19.1M | Sell |
568,399
-83,430
| -13% | -$3M | 0.16% | 173 |
|
|
2019
Q4 | $21.2M | Buy |
651,829
+90,287
| +16% | +$2.57M | 0.15% | 196 |
|
|
2019
Q3 | $14M | Buy |
561,542
+52,366
| +10% | +$1.5M | 0.11% | 242 |
|
|
2019
Q2 | $15.2M | Buy |
509,176
+72,154
| +17% | +$2.11M | 0.12% | 223 |
|
|
2019
Q1 | $11.7M | Buy |
437,022
+108,788
| +33% | +$3.3M | 0.1% | 260 |
|
|
2018
Q4 | $9.79M | Buy |
+328,234
| New | +$10.2M | 0.09% | 290 |
|
Other funds holding ATRC
HRCM
NAMI
BNP Paribas Asset Management's ATRC Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its AtriCure (ATRC) stake by 15% in Q2 2026, selling an estimated $4.6M and leaving 897,419 shares worth $25.1M. The position accounts for 0.03% of the portfolio, ranked #530.
BNP Paribas Asset Management first reported a position in ATRC in Q4 2018 and has held it in 31 quarters since. The position peaked at $38M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- BNP Paribas Asset Management held 897,419 shares of AtriCure worth $25.1M as of Q2 2026.
- BNP Paribas Asset Management sold 163,387 AtriCure shares in Q2 2026, an estimated $4.6M.
- AtriCure made up 0.03% of BNP Paribas Asset Management's portfolio in Q2 2026, its #530 holding.
- BNP Paribas Asset Management first reported a position in AtriCure in Q4 2018 and has held it in 31 quarters since.
- BNP Paribas Asset Management's AtriCure position peaked at $38M in Q4 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.